A new study by Future Market Insights (FMI) projects significant growth in the global protein A resins market, with forecasts indicating a jump from US$ 677.84 million in 2023 to an estimated US$ 1,477.01 million by 2033. This marks a robust compound annual growth rate (CAGR) of 8.1% over the next decade.
Protein A resins are critical components in the purification processes used in the production of monoclonal antibodies, a sector that has seen explosive growth due to their increasing application in therapeutic treatments and diagnostics. The rise in chronic diseases, a growing biopharmaceutical industry, and advancements in clinical research methodologies are driving the demand for more efficient biologics, thereby boosting the protein A resins market.
Request A Sample Copy of This Research Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1720
The detailed FMI report provides an in-depth analysis of the market dynamics, including the key drivers, challenges, opportunities, and emerging trends that are shaping the industry. The analysis includes insights into the technological innovations and regulatory frameworks that are influencing the market’s trajectory.
“With the growing demand for monoclonal antibodies and other biopharmaceuticals, the need for high-quality protein A resins is more critical than ever,” said an FMI analyst. “This market is set to expand significantly, offering substantial opportunities for stakeholders across the biotechnology and pharmaceutical industries.”
The report also segments the protein A resins market based on product type, application, and geography, providing a detailed understanding of the major factors influencing market growth across different regions and sectors.
Industry leaders and investors are advised to focus on innovation and scalability to capitalize on the upcoming opportunities in this rapidly growing market. Strategic investments in next-generation purification technologies and expansions in emerging markets are recommended to gain a competitive edge.
Factors Contributing to the Rise of CMOs in mAb Production:
- Limited In-House Capabilities: Many biotechnology companies lack the internal infrastructure and expertise required for mAb production.
- Supply Chain Complexity: Managing the complex supply chain associated with mAb manufacturing can be challenging.
- High Financial Investment: Establishing high-containment biologic facilities requires significant financial resources, posing a risk for individual companies.
Therefore, the outsourcing of mAb development and manufacturing to CMOs is expected to create a substantial demand for protein A resins, further propelling market growth.
This highlights the projected growth of the protein A resins market, driven primarily by the increasing demand for monoclonal antibody production and the crucial role played by Contract Manufacturing Organizations.
Request Report Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-1720
Top Highlights from the FMI’s Analysis of the Protein A Resins Market:
- The United States protein A resins industry is expected to acquire more than 93.5% value share of the North America market.
- Within Europe, the United Kingdom protein A resins industry is expected to take 24.1% of the pie in 2033.
- The China market is anticipated to enlarge at a CAGR of 9.8% over the upcoming years.
- High demand for natural protein A resin is expected to yield a large market share in 2023.
- Under the matrix category, the agarose-composed matrix of protein A resins is expected to record 85.8% of the market share in 2023.
- The antibody purification segment is projected to gain 74.8% of the global market.
- The biopharmaceutical manufacturers segment is expected to emerge as the chief end user of the market, gaining as high as 79.2% of the market in 2023.
Key Players in the Market are:
- GE Healthcare
- Thermo Fisher Scientific
- Kaneka Corporation,
- JNC Corporation
- Purolite Life Sciences
- Bio-Rad Laboratories, Inc.
- JSR Corporation (JSR Life Sciences LLC)
- Repligen
- Tosoh Bioscience, Merck Group (Merck Millipore)
- Novasep Holdings SAS, Agilent Technologies, Inc.
- GenScript, Abcam PLC (Expedeon Ltd.)
- Avantor Inc.
- Takara Bio, PerkinElmer, Inc.
- Suzhou Nanomicro Technology Co., Ltd
Purchase Now to Access Market Intelligence: https://www.futuremarketinsights.com/checkout/1720
Protein A Resins Market by Category:
Product:
- Natural Protein A Resin
- Recombinant Protein A Resin
Matrix:
- Agarose-based Matrix
- Glass or Silica-based Matrix
- Organic Polymer-based Matrix
Application:
- Immunoprecipitation
- Antibody Purification
End User:
- Biopharmaceutical Manufacturers
- Clinical Research Laboratories
- Academic Institutes
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube